Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Med Sci Sports Exerc. 2022 Sep 29;55(2):273–280. doi: 10.1249/MSS.0000000000003046

Table 4:

Multivariablea hazard ratio (95% CI) for risk of frailty according to categories of cumulative average leisure time physical activity in women ≥60y stratified by lean body mass and ageb

Quintiles of physical activity (MET hours/wk)
1 2 3 4 5 P trend P interaction

Total MET hours/wk
Lean body mass < median 1 0.74 (0.69, 0.80) 0.65 (0.60, 0.70) 0.54 (0.50, 0.58) 0.44 (0.40, 0.48) <0.001
Lean body mass >= median 1 0.80 (0.76, 0.84) 0.71 (0.67, 0.75) 0.63 (0.59, 0.67) 0.51 (0.47, 0.55) <0.001 0.002
Age <70 y 1 0.70 (0.64, 0.75) 0.59 (0.53, 0.64) 0.48 (0.43, 0.53) 0.40 (0.36, 0.45) <0.001
Age >= 70y 1 0.81 (0.77, 0.85) 0.73 (0.69, 0.77) 0.64 (0.60, 0.67) 0.51 (0.47, 0.54) <0.001 <0.001
Moderate activity MET hours/wk
Lean body mass < median 1 0.76 (0.71, 0.82) 0.71 (0.66, 0.77) 0.61 (0.56, 0.66) 0.49 (0.45, 0.54) <0.001
Lean body mass >= median 1 0.81 (0.77, 0.85) 0.73 (0.69, 0.77) 0.64 (0.60, 0.68) 0.53 (0.49, 0.58) <0.001 0.33
Age <70 y 1 0.74 (0.69, 0.81) 0.62 (0.56, 0.67) 0.53 (0.48, 0.58) 0.47 (0.41, 0.53) <0.001
Age >= 70y 1 0.82 (0.78, 0.86) 0.77 (0.73, 0.81) 0.67 (0.63, 0.70) 0.53 (0.49, 0.56) <0.001 <0.001
Vigorous activity MET hours/wk
Lean body mass < median 1 0.92 (0.86, 0.99) 0.81 (0.75, 0.87) 0.75 (0.70, 0.82) 0.70 (0.65, 0.77) <0.001
Lean body mass >= median 1 0.90 (0.85, 0.95) 0.87 (0.83, 0.92) 0.83 (0.78, 0.88) 0.79 (0.73, 0.85) <0.001 0.004
Age <70 y 1 0.84 (0.77, 0.91) 0.76 (0.70, 0.83) 0.72 (0.66, 0.79) 0.64 (0.57, 0.71) <0.001
Age >= 70y 1 0.94 (0.89, 0.99) 0.89 (0.84, 0.93) 0.83 (0.79, 0.88) 0.79 (0.75, 0.84) <0.001 <0.001
Activity duration (hour/wk)
<1.0 1 to <3.0 3.0 to <7.0 7.0 to <10.0 ≥10.0

Physical Activity time
Lean body mass < median 1 0.72 (0.67, 0.77) 0.55 (0.51, 0.59) 0.43 (0.38, 0.48) 0.35 (0.30, 0.40) <0.001
Lean body mass >= median 1 0.79 (0.75, 0.83) 0.63 (0.60, 0.67) 0.50 (0.45, 0.55) 0.47 (0.41, 0.53) <0.001 0.02
Age <70 y 1 0.70 (0.65, 0.76) 0.50 (0.46, 0.54) 0.43 (0.37, 0.50) 0.40 (0.34, 0.48) <0.001
Age >= 70y 1 0.80 (0.76, 0.84) 0.64 (0.61, 0.68) 0.49 (0.45, 0.53) 0.41 (0.36, 0.46) <0.001 <0.001
<1.0 1 to < 2.0 2 to < 4.0 ≥4.0

Moderate activity time
Lean body mass < median 1 0.81 (0.75, 0.86) 0.69 (0.64, 0.74) 0.58 (0.53, 0.63) <0.001
Lean body mass >= median 1 0.80 (0.76, 0.84) 0.72 (0.69, 0.76) 0.59 (0.55, 0.64) <0.001 0.25
Age <70 y 1 0.75 (0.70, 0.81) 0.62 (0.57, 0.67) 0.56 (0.50, 0.63) <0.001
Age >= 70y 1 0.83 (0.79, 0.87) 0.74 (0.71, 0.78) 0.59 (0.55, 0.63) <0.001 <0.001
Vigorous activity time
Lean body mass < median 1 0.80 (0.74, 0.85) 0.78 (0.72, 0.84) 0.67 (0.60, 0.74) <0.001
Lean body mass >= median 1 0.88 (0.84, 0.93) 0.86 (0.80, 0.91) 0.76 (0.69, 0.83) <0.001 0.005
Age <70 y 1 0.81 (0.74, 0.88) 0.70 (0.63, 0.77) 0.73 (0.63, 0.84) <0.001
Age >= 70y 1 0.86 (0.82, 0.90) 0.87 (0.82, 0.92) 0.71 (0.65, 0.77) <0.001 <0.001
a

Multivariable adjusted for age, BMI, energy intake, alcohol intake, AHEI-2010 score, post-menopausal hormone use, smoking, highest degree earned, use of the following medications: aspirin, beta blockers, hydrochlorthiazide, ACE inihibitors, calcium channel blockers, other antihypertensive medications, insulin, oral hypoglycemics, lipid lowering medication. Moderate and vigorous activities were mutually adjusted for each other.

b

Lean body mass < median: case = 6129, Lean body mass >= median: case= 10,350; age < 70y: case= 4406, age >=70: case= 12,073